Effects of low molecular weight heparin versus dabigatran on platelet aggregation in patients with stable coronary artery disease (2017)
- Authors:
- USP affiliated authors: NICOLAU, JOSÉ CARLOS - FM ; RAMIRES, JOSE ANTONIO FRANCHINI - FM ; KALIL FILHO, ROBERTO - FM
- Unidade: FM
- DOI: 10.1016/S0735-1097(17)33597-0
- Subjects: PLAQUETAS; PESO MOLECULAR; DOENÇAS CARDIOVASCULARES
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of the American College of Cardiology
- ISSN: 0735-1097
- Volume/Número/Paginação/Ano: v. 69, Issue 11, Supplement, 21 March, p. 208, 2017
- Conference titles: Annual Scientific Session and Expo (ACC)
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ARANTES, Flavia Bittar Britto et al. Effects of low molecular weight heparin versus dabigatran on platelet aggregation in patients with stable coronary artery disease. Journal of the American College of Cardiology. New York: Elsevier. Disponível em: https://doi.org/10.1016/S0735-1097(17)33597-0. Acesso em: 19 fev. 2026. , 2017 -
APA
Arantes, F. B. B., Menezes, F., Franci, A., Barbosa, C., Dalçóquio, T. F., Nakashima, C. K., et al. (2017). Effects of low molecular weight heparin versus dabigatran on platelet aggregation in patients with stable coronary artery disease. Journal of the American College of Cardiology. New York: Elsevier. doi:10.1016/S0735-1097(17)33597-0 -
NLM
Arantes FBB, Menezes F, Franci A, Barbosa C, Dalçóquio TF, Nakashima CK, Ferrari A, Scanavini Filho MA, Furtado R, Baracioli L, Ramires J, Kalil-Filho R, Nicolau JC. Effects of low molecular weight heparin versus dabigatran on platelet aggregation in patients with stable coronary artery disease [Internet]. Journal of the American College of Cardiology. 2017 ; 69 208.[citado 2026 fev. 19 ] Available from: https://doi.org/10.1016/S0735-1097(17)33597-0 -
Vancouver
Arantes FBB, Menezes F, Franci A, Barbosa C, Dalçóquio TF, Nakashima CK, Ferrari A, Scanavini Filho MA, Furtado R, Baracioli L, Ramires J, Kalil-Filho R, Nicolau JC. Effects of low molecular weight heparin versus dabigatran on platelet aggregation in patients with stable coronary artery disease [Internet]. Journal of the American College of Cardiology. 2017 ; 69 208.[citado 2026 fev. 19 ] Available from: https://doi.org/10.1016/S0735-1097(17)33597-0 - The role of oral beta blocker in a real-world population with non-ST segment elevation acute coronary syndromes
- Platelet aggregability, coagulation, fibrinolysis and inflammation in patients with coronary artery disease and previous cerebrovascular ischemic event
- Influence of proven oral therapies in the very old with acute coronary syndromes: A 15 year experience
- Influence of Direct Thrombin Inhibitor and Low Molecular Weight Heparin on Platelet Function in Patients with Coronary Artery Disease: a Prospective Interventional Trial
- Pacientes Diabéticos com Síndromes Coronárias Agudas têm um Limiar Maior para a Dor Isquêmica?
- Platelet function, coagulation and fibrinolysis in patients with previous coronary and cerebrovascular ischemic events
- Sonothrombolysis in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
- O escore de risco de sangramento como preditor de mortalidade em pacientes com síndromes coronarianas agudas
- The impact of sonothrombolysis on left ventricular diastolic function and left atrial mechanics preventing left atrial remodeling in patients with ST elevation acute myocardial infarction
- Diagnostic Ultrasound Impulses Improve Microvascular Flow in Patients With STEMI Receiving Intravenous Microbubbles
Informações sobre o DOI: 10.1016/S0735-1097(17)33597-0 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
